Jacobs Levy Equity Management
CYTR

Jacobs Levy Equity Management’s CytRx Corp CYTR Stock Holding History

Jacobs Levy Equity Management’s Portfolio CYTR Stock Details CYTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-9,023
Closed -$121K – 1247
2016
Q2 		$121K Buy
+9,023
New +$150K ﹤0.01% 1076

Other funds holding CYTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Jacobs Levy Equity Management's CYTR Position: Q3 2016 in Review

Jacobs Levy Equity Management sold out of CytRx Corp (CYTR) in Q3 2016, closing a stake of 9,023 shares — an estimated $121K sold.

Jacobs Levy Equity Management first reported a position in CYTR in Q2 2016 and held it in 1 quarter. The position peaked at $121K in Q2 2016. 72 funds tracked by Wall St. Rank hold CYTR as of Q3 2016.

  • Jacobs Levy Equity Management reported no remaining CytRx Corp position as of Q3 2016 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 9,023 CytRx Corp shares in Q3 2016, an estimated $121K.
  • Jacobs Levy Equity Management first reported a position in CytRx Corp in Q2 2016 and held it in 1 quarter.
  • Jacobs Levy Equity Management's CytRx Corp position peaked at $121K in Q2 2016.
  • 72 funds tracked by Wall St. Rank held CytRx Corp as of Q3 2016.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2016, filed 14 Nov 2016.